Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + Metronomic Chemotherapy Maintenance in High-Risk Pediatric Solid Tumors
NCT04469530Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Sep 2020
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in solid tumor, sponsored by Emory University. Started Sep 2020; status: recruiting.
02
Drugs
sirolimus
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04469530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04469530.